Market Price

22.78 

-0.63 -2.7%

as of Nov 14 '18

52 Week Range:

22.78 33.73


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. The company offers angioscope, a fiber optic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters that temporarily occlude the blood flow; and perfusion catheters to temporarily perfuse the blood and other fluids into the vasculature. It also provides carotid shunts that temporarily shunt the blood to the brain during the removal of plaque from the carotid artery in a carotid endarterectomy surgery; powered phlebectomy devices to remove varicose veins; and radiopaque tape, a medical-grade tape applied to the skin that enables interventionists to cross-refer between the inside and the outside of a patient's body, and allows them to locate tributaries or lesions beneath the skin. In addition, the company offers remote endarterectomy devices to remove plaque from arteries in the leg; valvulotomes that cuts valves in the saphenous vein to function as an artery to carry blood past diseased arteries to the lower leg or the foot; and vascular grafts to bypass or replace diseased arteries. Further, it provides vascular patches, which are used for closure of vessels after surgical intervention, as well as endarterectomy and other vascular reconstruction; vessel closure systems to attach vessels to one another with titanium clips instead of sutures; and Reddick cholangiogram catheters to inject dye into the cystic duct during laparoscopic cholecystectomy, as well as laparoscopic accessory for use in laparoscopic gall bladder removal. LeMaitre Vascular, Inc. markets its products through a direct sales force and distributors. The company was formerly known as Vascutech, Inc. and changed its name to LeMaitre Vascular, Inc. in April 2001. LeMaitre Vascular, Inc. was founded in 1983 and is headquartered in Burlington, Massachusetts.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17
Equity (BVPS) 4.61
growth rate
Earnings BIT 7.23
11.15
16.34
21.60
growth rate 54.2% 46.5% 32.2%
Avg.PE 22.86
growth rate
ROA -5.74
2.87
10.01
3.49
4.19
4.80
5.15
9.01
11.00
15.05
growth rate 100.0% 248.8% -65.1% 20.1% 14.6% 7.3% 75.0% 22.1% 36.8%
ROE -7.03
3.40
11.96
4.10
4.90
5.85
6.28
10.62
12.81
17.41
growth rate 100.0% 251.8% -65.7% 19.5% 19.4% 7.4% 69.1% 20.6% 35.9%
ROIC -7.84
3.37
11.92
4.09
4.80
5.86
6.28
10.61
12.75
17.28
growth rate 100.0% 253.7% -65.7% 17.4% 22.1% 7.2% 69.0% 20.2% 35.5%
Cur. Ratio 5.35
6.04
4.13
6.07
4.66
4.08
4.84
5.61
5.63
6.09
growth rate 12.9% -31.6% 47.0% -23.2% -12.5% 18.6% 15.9% 0.4% 8.2%
Quick Ratio 4.11
4.85
2.99
4.38
3.04
2.48
2.94
3.80
3.58
4.30
growth rate 18.0% -38.4% 46.5% -30.6% -18.4% 18.6% 29.3% -5.8% 20.1%
Leverage 1.19
1.18
1.21
1.15
1.19
1.25
1.19
1.16
1.16
1.15
growth rate -0.8% 2.5% -5.0% 3.5% 5.0% -4.8% -2.5% 0.0% -0.9%
Balance Sheet Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17
Acct.Receivable 10.80
11.97
13.19
15.00
growth rate 10.8% 10.2% 13.7%
Acct.Payable 1.13
1.37
1.22
1.54
growth rate 21.2% -10.9% 26.8%
Cur.Assets 48.59
58.18
59.03
80.31
growth rate 19.8% 1.5% 36.1%
Total Assets 81.49
90.70
101.92
126.32
growth rate 11.3% 12.4% 23.9%
Cash 18.69
27.45
24.29
19.10
growth rate 46.9% -11.5% -21.4%
Inventory 16.71
15.21
19.58
21.05
growth rate -9.0% 28.8% 7.5%
Cur.Liabilities 10.04
10.37
10.48
13.19
growth rate 3.3% 1.1% 25.8%
Liabilities 13.29
12.82
14.42
16.55
growth rate -3.5% 12.5% 14.8%
Equity 68.21
77.88
87.50
109.77
growth rate 14.2% 12.4% 25.5%
Common Shares 16.00
16.00
16.00
16.00
16.00
16.00
17.00
18.00
19.00
20.00
growth rate 0.0% 0.0% 0.0% 0.0% 0.0% 6.3% 5.9% 5.6% 5.3%
Cash Flow Statement Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17
Capital Expenditures 1.17
2.27
2.84
6.42
growth rate 93.6% 25.0% 125.9%
Cash Dividends 2.31
2.85
3.32
4.18
growth rate 23.3% 16.8% 25.8%
Cash From OA 5.51
11.44
16.90
22.87
growth rate 107.5% 47.7% 35.4%
FCF per Share 0.61
growth rate
FCF 4.00
4.00
1.00
3.00
2.00
4.00
9.00
14.00
16.00
growth rate 0.0% -75.0% 200.0% -33.3% 100.0% 125.0% 55.6% 14.3%
Income Statement Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17
Sales 70.41
77.61
89.15
100.87
growth rate 10.2% 14.9% 13.1%
Op.Income 7.23
11.15
16.34
21.60
growth rate 54.2% 46.5% 32.2%
IBT 6.32
11.42
16.24
21.11
growth rate 80.8% 42.2% 30.0%
Net Income 3.92
7.76
10.59
17.18
growth rate 98.2% 36.5% 62.2%
EPS -0.21
0.10
0.37
0.13
0.16
0.20
0.23
0.42
0.55
0.86
growth rate 100.0% 270.0% -64.9% 23.1% 25.0% 15.0% 82.6% 31.0% 56.4%
Gross Profit 47.74
53.42
62.94
70.70
growth rate 11.9% 17.8% 12.3%
R&D 4.67
5.48
6.14
6.64
growth rate 17.3% 12.1% 8.1%

Quarterly Statements

Item Name Dec '17 Mar '18 Jun '18 Sep '18
Earnings BIT 5.72
4.86
5.67
4.61
growth rate -15.0% 16.5% -18.6%
Balance Sheet Dec '17 Mar '18 Jun '18 Sep '18
Acct.Receivable 15.00
14.51
15.23
13.02
growth rate -3.3% 5.0% -14.5%
Acct.Payable 1.54
1.44
1.66
1.63
growth rate -6.7% 15.1% -1.8%
Cur.Assets 80.31
84.01
92.36
86.81
growth rate 4.6% 10.0% -6.0%
Total Assets 126.32
129.41
137.10
144.33
growth rate 2.4% 5.9% 5.3%
Cash 19.10
22.78
19.64
20.10
growth rate 19.3% -13.8% 2.4%
Inventory 21.05
21.83
21.67
23.88
growth rate 3.7% -0.8% 10.2%
Cur.Liabilities 13.19
12.64
13.12
15.75
growth rate -4.2% 3.7% 20.1%
Liabilities 16.55
15.94
16.36
18.98
growth rate -3.7% 2.6% 16.0%
Equity 109.77
113.47
120.74
125.35
growth rate 3.4% 6.4% 3.8%
Common Shares 0.21
0.21
0.21
0.21
growth rate 0.5% 0.0% 1.4%
Cash Flow Statement Dec '17 Mar '18 Jun '18 Sep '18
Capital Expenditures 1.64
0.43
0.80
growth rate -73.9% 88.1%
Cash Dividends 1.06
2.70
2.70
growth rate 155.1% 0.0%
Cash From OA 6.77
3.75
4.88
growth rate -44.6% 30.0%
FCF 5.13
3.32
4.07
growth rate -35.2% 22.5%
Income Statement Dec '17 Mar '18 Jun '18 Sep '18
Sales 26.15
25.99
27.02
24.17
growth rate -0.6% 4.0% -10.6%
Op.Income 5.72
4.86
5.67
4.61
growth rate -15.0% 16.5% -18.6%
IBT 6.33
4.92
11.55
4.73
growth rate -22.3% 134.9% -59.0%
Net Income 4.28
3.85
8.75
4.31
growth rate -10.1% 127.1% -50.7%
Gross Profit 18.25
18.47
18.99
17.26
growth rate 1.2% 2.8% -9.2%
R&D 1.58
1.83
1.99
2.04
growth rate 15.3% 8.9% 2.5%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

A+ (93.74)

YOY Growth Grade:

B (82.07)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 22.86 21.70
EPS / Growth 1.05

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 20.5%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 20.5% 20.5% 20.5%
Future PE 0.01 21.26 21.26
Future EPS 6.75 6.75 6.75
Value Price
MOS %
0.02
-99.9%
35.46
55.7%
35.46
55.7%
MOS Price 0.01 17.73 17.73
IRT 8.28 8.28 8.28

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.